Drug Profile
Research programme: respiratory viral inhibitor - Pharmasset
Alternative Names: NHC; Respiratory viral inhibitor research programme - PharmassetLatest Information Update: 20 Feb 2008
Price :
$50
*
At a glance
- Originator Pharmasset
- Class Nucleosides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections